EP3518912
DUAL-ACTION ELAFIBRANOR METFORMIN SALT FOR TREATING OBESITY ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND HYPERTRIGLYCERIDAEMIA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.9.2017EP published:
30.12.2020EP application number:
17781051.2
EPO information:
European Patent Register
Max expiry date:
27.9.2037
Title:
DUAL-ACTION ELAFIBRANOR METFORMIN SALT FOR TREATING OBESITY ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND HYPERTRIGLYCERIDAEMIA
Timeline
Today
28.9.2017EP application
30.12.2020EP Publication
Owner
Name:
NashpharmAddress:
18 avenue Bellevue, 06270 Villeneuve Loubet, FR
Inventor
Name:
LARUELLE, ClaudeAddress:
06270 Villeneuve Loubet, FR
Name:
BONNAFOUS, LudovicAddress:
06370 Mouans Sartoux, FR
Priority
Number:
1659435Date:
30.9.2016Country:
FR
Classification
Categories:
A61K 31/155, A61K 31/192, C07C 279/26, C07C 323/62, A61K 9/00, A61P 1/16, A61P 3/06, A61P 3/10, A61P 3/04, A61P 9/00